Skip to main content
. 2017 Mar 15;2017(3):CD012599. doi: 10.1002/14651858.CD012599

Habayeb 2010.

Clinical features and settings Routine screening
Participants 1507 participants
UK ‐ Fetal medicine unit
September 2007 ‐ December 2008
Pregnant women
Median maternal age 35.4 years (range 18‐49 years)
9‐10, 11‐13 and > 14 weeks' gestation
Study design Cohort
Target condition and reference standard(s) Down's syndrome: 12 cases
Reference standards: karyotyping or follow‐up to birth
Index and comparator tests Maternal age
Early first trimester PAPP‐A (9 weeks' gestation) (AutoDELFIA PAPP‐A kit, PerkinElmer LAS (UK) Ltd)
First trimester NT (11‐13 weeks' gestation) (General Electric E8, Voluson 730 Pro, GE Healthcare)
Second trimester AFP, free ßhCG and uE3 (at or after 14 weeks' gestation) (AutoDELFIA(TM) time‐resolved fluoroimmunoassay, PerkinElmer Life Sciences)
Second trimester tests given if first trimester risk low (< 1:100) or invasive testing declined
Cut‐point for second‐stage risk 1:250
Follow‐up Data recorded on a fetal medicine database and combined with data held on separate databases for pregnancy outcome and the regional cytogenetic laboratory. Cytogenetic test results available for all women delivering in the region
Aim of study To audit a model combining early PAPP‐A with NT and early triple test
Test characteristics  
Reference standard used  
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Routine screening of typical pregnant population
Acceptable reference standard? 
 All tests Yes Karyotyping or follow‐up to birth
Partial verification avoided? 
 All tests Unclear Unclear if all women received a reference standard
Differential verification avoided? 
 All tests No Choice of reference standard depended on index test results
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice
Uninterpretable results reported? 
 All tests No No details given for test failures/uninterpretable measurements
Withdrawals explained? 
 All tests No No details of withdrawals given